US developer to make extended stay debut with My Place deal
US: Developer Opwest Partners, which is primarily focused on higher-end hotel and residential projects, is to diversify its portfolio by developing several extended stay hotels.
US: Developer Opwest Partners, which is primarily focused on higher-end hotel and residential projects, is to diversify its portfolio by developing several extended stay hotels.
USA: Extended-stay hotel brand, My Place Hotels, and real estate development and investment firm, Rimrock Companies, have entered into a two-phase franchise and development agreement for 10 extended-stay hotels across southern America.
US: Tech-enabled hospitality and multifamily operator Placemakr has opened its 81-unit Navy Yard aparthotel in Washington DC.
Saudi Arabia: Baheej Tourism Development Company, a joint venture between ASFAR, the Saudi tourism investment company owned by PIF, and the Tamimi-AWN Alliance, has signed an agreement with operator Kerten Hospitality for its premium Cloud7 brand in Yanbu.
UK: Management company Switch Hospitality has completed the redevelopment of its aparthotel Birmingham with the addition of an on-site store.
UK: Eden Grove Developments Limited, the freeholder of The Coal Exchange Hotel in Cardiff, has appointed KEW Planning to redevelop the site and explore the addition of serviced apartments.
US: Choice Hotels’ midscale extended stay brand Everhome Suites has debuted in Nampa, Idaho, marking the third opening for the brand.
US: The independently owned and operated Shorehouse Hotel, located in Buena Vista, Colorado, has opened.
UAE: The Ascott Limited has unveiled ambitious expansion plans to grow its portfolio in the MENA region.
UK: Property management and development company The Nurtur Group will open its first serviced apartments offering in Preston, Lancashire, on 1st July.
UAE: Rotana has revealed its growing pipeline of planned openings in the Middle East, Africa and the UK..
US: The 2024 First Quarter US Extended-Stay Hotels Report, published by The Highland Group, reveals a decline in RevPAR for the first time in three years.